Drug patents in poor countries

被引：0

|

作者：

Love, J ^{[1
]}

机构：

[1] Consumer Project Technol, Washington, DC USA

来源：

HEALTH AFFAIRS | 2004年 / 23卷 / 05期

关键词：

D O I：

10.1377/hlthaff.23.5.279

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

引用

收藏

页码：279 / 279

页数：1

相关论文

共 50 条

[1] Poor countries press for extension of exemption from drug patents
Gulland, Anne
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2015, 351
[2] Effect of drug patents in developing countries
Schull, M
[J]. BRITISH MEDICAL JOURNAL, 2000, 321 (7264): : 833 - 834
[3] Drug access in poor countries
Sebbag, Robert
[J]. BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2007, 191 (08): : 1601 - 1602
[4] POOR NATIONS GET PASS ON PROTECTING DRUG PATENTS
不详
[J]. CHEMICAL & ENGINEERING NEWS, 2015, 93 (45) : 26 - 26
[5] Glaxo cuts drug prices in poor countries
不详
[J]. CHEMICAL & ENGINEERING NEWS, 2003, 81 (18) : 14 - 14
[6] TB drug prices slashed for poor countries
Hagmann, M
[J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2001, 79 (09) : 904 - 905
[7] GSK cuts drug prices in poor countries
不详
[J]. TCE, 2009, (813): : 6 - 6
[8] Drug companies are ignoring health crisis in poor countries
O'Dowd, Adrian
[J]. BRITISH MEDICAL JOURNAL, 2007, 335 (7630): : 1111 - 1111
[9] Drug patents
Tremblay, JF
[J]. CHEMICAL & ENGINEERING NEWS, 2006, 84 (06) : 18 - 18
[10] Developing countries call on WHO to focus on public health issues not drug patents
Zarocostas, John
[J]. BRITISH MEDICAL JOURNAL, 2010, 340

← 1 2 3 4 5 →